Worth Venture Partners’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,088,938
| Closed | -$311K | – | 173 |
|
|
2023
Q3 | $311K | Hold |
1,088,938
| – | – | 0.18% | 94 |
|
|
2023
Q2 | $524K | Buy |
1,088,938
+35,130
| +3% | +$16.9K | 0.29% | 76 |
|
|
2023
Q1 | $685K | Sell |
1,053,808
-17,130
| -2% | -$11.1K | 0.33% | 71 |
|
|
2022
Q4 | $503K | Buy |
1,070,938
+107,137
| +11% | +$50.4K | 0.3% | 78 |
|
|
2022
Q3 | $799K | Buy |
963,801
+392,312
| +69% | +$325K | 0.49% | 57 |
|
|
2022
Q2 | $846K | Hold |
571,489
| – | – | 0.5% | 58 |
|
|
2022
Q1 | $727K | Buy |
571,489
+58,400
| +11% | +$74.3K | 0.34% | 72 |
|
|
2021
Q4 | $837K | Buy |
513,089
+298,059
| +139% | +$486K | 0.41% | 63 |
|
|
2021
Q3 | $595K | Hold |
215,030
| – | – | 0.27% | 83 |
|
|
2021
Q2 | $647K | Buy |
215,030
+17,130
| +9% | +$51.5K | 0.24% | 83 |
|
|
2021
Q1 | $807K | Buy |
+197,900
| New | +$807K | 0.39% | 63 |
|